MAPT and Alzheimer disease: There were correlations between CSF VILIP-1 levels and CSF t-tau, p-tau-181, and brain volume in patients with Alzheimer’s disease, and the VILIP-1/Aβ42 ratio was prognostic for future cognitive impairment in normal individuals [332].